Pediatric Psoriasis: Infection Risk Low With Systemic Meds Pediatric Psoriasis: Infection Risk Low With Systemic Meds

The results are from a large cohort study that estimated the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news